56 related articles for article (PubMed ID: 22710726)
1. Single nucleotide polymorphisms in the regulatory region of gonadotropin-releasing hormone receptor gene and breast cancer susceptibility.
Lattrich C; Müller AK; Schüler S; Häring J; Ruoff A; Treeck O; Ortmann O
Oncol Rep; 2012 Sep; 28(3):1091-5. PubMed ID: 22710726
[TBL] [Abstract][Full Text] [Related]
2. LFA-1 gene polymorphisms are associated with the sporadic infiltrative duct breast carcinoma in Chinese Han women of Heilongjiang Province.
Fu Z; Jiao M; Zhang M; Xu F; Yuan W; Pang D; Li D
Breast Cancer Res Treat; 2011 May; 127(1):265-71. PubMed ID: 20953905
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
4. [Association between polymorphisms of interleukin-6 gene promoter and breast cancer].
He KL; Li YP; Lv YG; Zhang DJ; Wang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1220-2. PubMed ID: 22078452
[TBL] [Abstract][Full Text] [Related]
5. Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.
Sung H; Lee KM; Choi JY; Han S; Lee JY; Li L; Park SK; Yoo KY; Noh DY; Ahn SH; Kang D
Breast Cancer Res Treat; 2011 Dec; 130(3):939-51. PubMed ID: 21766210
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development.
Theodoropoulos GE; Saridakis V; Karantanos T; Michalopoulos NV; Zagouri F; Kontogianni P; Lymperi M; Gazouli M; Zografos GC
Breast; 2012 Aug; 21(4):534-8. PubMed ID: 22560646
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene polymorphisms and breast cancer susceptibility and prognosis.
Smith KC; Bateman AC; Fussell HM; Howell WM
Eur J Immunogenet; 2004 Aug; 31(4):167-73. PubMed ID: 15265021
[TBL] [Abstract][Full Text] [Related]
8. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
9. A functional promoter polymorphism in the TERT gene does not affect inherited susceptibility to breast cancer.
Varadi V; Brendle A; Grzybowska E; Johansson R; Enquist K; Butkiewicz D; Pamula-Pilat J; Pekala W; Hemminki K; Lenner P; Försti A
Cancer Genet Cytogenet; 2009 Apr; 190(2):71-4. PubMed ID: 19380022
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic variations in exon 10 of the luteinizing hormone receptor: functional consequences and associations with breast cancer.
Piersma D; Verhoef-Post M; Look MP; Uitterlinden AG; Pols HA; Berns EM; Themmen AP
Mol Cell Endocrinol; 2007 Sep; 276(1-2):63-70. PubMed ID: 17709176
[TBL] [Abstract][Full Text] [Related]
11. Two functionally relevant polymorphisms in the human progesterone receptor gene (+331 G/A and progins) and the predisposition for breast and/or ovarian cancer.
Romano A; Lindsey PJ; Fischer DC; Delvoux B; Paulussen AD; Janssen RG; Kieback DG
Gynecol Oncol; 2006 May; 101(2):287-95. PubMed ID: 16360811
[TBL] [Abstract][Full Text] [Related]
12. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Klaes R; Chen B; Butkiewicz D; Pamula J; Pekala W; Försti A
Endocr Relat Cancer; 2005 Dec; 12(4):917-28. PubMed ID: 16322331
[TBL] [Abstract][Full Text] [Related]
13. Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.
Wang Y; McCullough ML; Stevens VL; Rodriguez C; Jacobs EJ; Teras LR; Pavluck AL; Thun MJ; Calle EE
Anticancer Res; 2007; 27(1B):589-93. PubMed ID: 17348446
[TBL] [Abstract][Full Text] [Related]
14. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
15. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
16. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.
Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta gene polymorphisms and susceptibility to uterine fibroids.
Fischer C; Juhasz-Boess I; Lattrich C; Ortmann O; Treeck O
Gynecol Endocrinol; 2010 Jan; 26(1):4-9. PubMed ID: 19639498
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis.
Försti A; Jin Q; Altieri A; Johansson R; Wagner K; Enquist K; Grzybowska E; Pamula J; Pekala W; Hallmans G; Lenner P; Hemminki K
Breast Cancer Res Treat; 2007 Jan; 101(1):83-93. PubMed ID: 16807673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
